Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
At GIANT Health Event #GIANT2025, meet with exhibitor Cineon to discuss ELE-Stress - an immersive resource hub developed with Torbay & South Devon NHS Foundation Trust and the University of Bath.
Powered by Cineon’s Empathic Learning Engine (ELE), it offers:
Adaptive,…
AI-Powered Nutrition: The Future of Preventive Health
Meet Dr. Maria Kardakova, Founder & CEO of iCook Health, at the GIANT Health Conference 2025. A Registered Nutritionist and PhD in Biosciences & Medicine, Maria is pioneering the integration of AI, biomarkers,…